The NHS Business Services Authority (NHSBSA) has informed us that from 12 October 2023, the Manage Your Service (MYS) dashboard layout will be changing following user feedback. The changes will see the current tabs move to the left-hand side of the page and the tabs will be reordered and listed in alphabetical order. The image
Read morePolitical party conference season is now in full swing and over the last week Community Pharmacy England has been at the Conservative Party Conference in Manchester. We hosted an event with influential MPs, charities, local councillors and patient advocates, and we have been talking to wider contacts such as think tanks and journalists. We’ll be
Read moreCommunity Pharmacy England and others have contributed to a report examining the impact of workforce wellbeing on pharmacy teams and how it can be addressed. The Pharmacy Workforce Wellbeing Roundtable Report has been published by the Royal Pharmaceutical Society (RPS) and Pharmacist Support following a roundtable discussion held earlier this year. Community Pharmacy England Director
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Progesterone (Lutigest®) 100mg vaginal tablets and Progesterone (Crinone®) 8% progesterone vaginal gel. MSN/2023/093 Tier 2 – medium impact Date of issue 3rd October 2023 Progesterone (Lutigest®) 100mg vaginal tablets are out of stock until late December 2023. Progesterone (Crinone®) 8% progesterone
Read moreMolnlycke® Healthcare has confirmed that they have ceased manufacturing of all Mepilex® Border and Mepilex® Border Lite dressings (other products in the Mepilex® range are unaffected ). In the coming months, both dressings will deleted from the Appliances (Part IXA) section of the Drug Tariff. Once deleted from the Tariff any prescriptions for these dressings
Read moreCommunity Pharmacy England on behalf of pharmacy owners (our members) made further applications to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), resulting in a further 9 new products being added to the ‘Drugs for which Discount is Not Deducted’ (DND) list from 1 October 2023. This takes
Read moreNHS England has asked us to remind pharmacy owners that they can order the following COVID-19 antivirals free of charge from Alliance Healthcare: Molnupiravir 200mg capsules (Lagevrio 200mg capsules) Nirmatrelvir 150mg tablets and Ritonavir 100mg tablets (Paxlovid 150mg/100mg tablets) They recommend pharmacies keep one or two courses in stock, depending on usual demand, to dispense against
Read moreDuring the month of September 2023, Community Pharmacy England received several reports from pharmacies unable to obtain certain Rosemont Pharmaceutical Ltd products at or below the published Drug Tariff prices. A price concession application for these products was not required because of the price change mechanism rules. The reimbursement prices are set out in the table below:
Read moreWe have today published the 2022/23 annual report for Community Pharmacy England, reflecting on our work in the past year on behalf of all pharmacy owners. This has been an incredibly challenging year for the community pharmacy sector, and we continue to fight hard to improve the outlook on both funding and operational pressures. The
Read moreFollowing discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (29/09/2023) announced the following final list of price concessions for September 2023: Drug Pack size Price concession Atorvastatin 80mg tablets 28 £5.32 Brimonidine 0.2% eye drops 5 £3.20
Read more
